Publication:
Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHA2DS2 Score in Turkey

dc.contributor.authorErgin, Oguzhan G.
dc.contributor.authorKockaya, G.
dc.contributor.authorCaliskan, Z.
dc.contributor.authorOkcun, S.
dc.contributor.authorKurnaz, M.
dc.contributor.authorBuyuktuna, N.
dc.contributor.authorSaylan, M.
dc.date.accessioned2020-06-21T12:20:04Z
dc.date.available2020-06-21T12:20:04Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Ergin, Oguzhan G.] 19 Mayis Univ, Samsun, Turkey -- [Kockaya, G.] ECONiX, Ankara, Turkey -- [Caliskan, Z.] Hacettepe Univ, Ankara, Turkey -- [Okcun, S. -- Kurnaz, M.] ECONiX, Istanbul, Turkey -- [Buyuktuna, N. -- Buyukisik, T.en_US
dc.description.abstracten_US
dc.identifier.endpageS552en_US
dc.identifier.issn1098-3015
dc.identifier.issn1524-4733
dc.identifier.startpageS552en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10503
dc.identifier.volume22en_US
dc.identifier.wosWOS:000503167001069
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.journalValue in Healthen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHA2DS2 Score in Turkeyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files